Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 臨床醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99590
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor湯頌君zh_TW
dc.contributor.advisorSung-Chun Tangen
dc.contributor.author鄭雅文zh_TW
dc.contributor.authorYa-Wen Chengen
dc.date.accessioned2025-09-16T16:12:42Z-
dc.date.available2025-09-17-
dc.date.copyright2025-09-16-
dc.date.issued2025-
dc.date.submitted2025-08-02-
dc.identifier.citation1. Berkhemer OA, Fransen PS, Beumer D, et al. A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med. 2015;372(1):11-20.
2. Goyal M, Demchuk AM, Menon BK, et al. Randomized assessment of rapid endovascular treatment of ischemic stroke. N Engl J Med. 2015;372(11):1019-1030.
3. Campbell BC, Mitchell PJ, Kleinig TJ, et al. Endovascular therapy for ischemic stroke with perfusion-imaging selection. N Engl J Med. 2015;372(11):1009-1018.
4. Jovin TG, Chamorro A, Cobo E, et al. Thrombectomy within 8 hours after symptom onset in ischemic stroke. N Engl J Med. 2015;372(24):2296-2306.
5. Saver JL, Goyal M, Bonafe A, et al. Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. N Engl J Med. 2015;372(24):2285-2295.
6. Albers GW, Marks MP, Kemp S, et al. Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. N Engl J Med. 2018;378(8):708-718.
7. Nogueira RG, Jadhav AP, Haussen DC, et al. Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. N Engl J Med. 2018;378(1):11- 21.
8. Yoshimura S, Sakai N, Yamagami H, et al. Endovascular therapy for acute stroke with a large ischemic region. N Engl J Med. 2022;386(14):1303-1313.
9. Sarraj A, Hassan AE, Abraham MG, et al. Trial of endovascular thrombectomy for large ischemic strokes. N Engl J Med. 2023;388(14):1259-1271.
10. Huo X, Ma G, Tong X, et al. Trial of endovascular therapy for acute ischemic stroke with large infarct. N Engl J Med. 2023;388(14):1272-1283.
11. Meijer FJ, Steens SC, Tuladhar AM, van Dijk ED, Boogaarts HD. Contrast- induced encephalopathy—neuroimaging findings and clinical relevance. Neuroradiology. 2022;64(6):1265-1268.
12. Leong S, Fanning N. Persistent neurological deficit from iodinated contrast encephalopathy following intracranial aneurysm coiling: a case report and review of the literature. Interv Neuroradiol. 2012;18(1):33-41.
13. Quintas-Neves M, Araújo JM, Xavier SA, Amorim JM, Cruz E Silva V, Pinho J. Contrast-induced neurotoxicity related to neurological endovascular procedures: a systematic review. Acta Neurol Belg. 2020;120:1419-1424.
14. Vazquez S, Graifman G, Spirollari E, et al. Incidence and risk factors for acute transient contrast-Induced neurologic deficit: a systematic review with meta-analysis. Stroke Vasc Interv Neurol. 2022;2(1):e000142.
15. Chu YT, Lee KP, Chen CH, et al. Contrast-induced encephalopathy after endovascular thrombectomy for acute ischemic stroke. Stroke. 2020;51(12):3756- 3759.
16. Davis PW, Krisanapan P, Tangpanithandee S, et al. Contrast-induced encephalopathy in patients with chronic kidney disease and end-stage kidney disease: a systematic review and meta-analysis. Medicines. 2023;10(8):46.
17. Fischer-Williams M, Gottschalk P, Browell J. Transient cortical blindness: an unusual complication of coronary angiography. Neurology. 1970;20(4):353-353.
18. Otsubo H, Yoshie T, Araga T, et al. A case report of Contrast-Induced encephalopathy after repeated percutaneous transluminal angioplasty for acute middle cerebral artery occlusion. J Neuroendovascular Ther. 2022;16(7):371-375.
19. Maclean MA, Rogers PS, Muradov JH, et al. Contrast-Induced Encephalopathy and the Blood-Brain Barrier. Can J Neurol Sci. 2025;52(1):85-94.
20. Stebner A, Bosshart S, Hainc N, et al. Contrast-Induced encephalopathy: A case series analysis. Ann Indian Acad Neurol. 2024;27(4):403-407.
21. Zidan M, Ghaei S, Bode F, Radbruch A, Dorn F. Early detection of contrast- induced encephalopathy after mechanical thrombectomy using flat-detector CT: incidence, risk factors, and clinical implications. Neuroradiology. 2025;67(5):1153- 1162.
22. Chen Z, Zhang Y, Su Y, Sun Y, He Y, Chen H. Contrast extravasation is predictive of poor clinical outcomes in patients undergoing endovascular therapy for acute ischemic stroke in the anterior circulation. J Stroke Cerebrovasc Dis. 2020;29(1):104494.
23. Merali Z, Huang K, Mikulis D, Silver F, Kassner A. Evolution of blood-brain- barrier permeability after acute ischemic stroke. PloS One. 2017;12(2):e0171558.
24. Bernardo-Castro S, Sousa JA, Brás A, et al. Pathophysiology of blood–brain barrier permeability throughout the different stages of ischemic stroke and its implication on hemorrhagic transformation and recovery. Front Neurol. 2020;11:594672.
25. Okada T, Suzuki H, Travis ZD, Zhang JH. The stroke-induced blood-brain barrier disruption: current progress of inspection technique, mechanism, and therapeutic target. Curr Neuropharmacol. 2020;18(12):1187-1212.
26. Yu J, George Dangas M. New insights into the risk factors of contrast-induced encephalopathy. J Endovasc Ther. 2011;18(4):545.
27. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. The Lancet. 2000;355(9216):1670-1674.
28. García-Tornel A, Carvalho V, Boned S, et al. Improving the evaluation of collateral circulation by multiphase computed tomography angiography in acute stroke patients treated with endovascular reperfusion therapies. Interv Neurol. 2016;5(3-4):209-217.
29. Kocabay G, Karabay C, Kalayci A, et al. Contrast-induced neurotoxicity after coronary angiography. Herz. 2014;39(4):522.
30. Li M, Liang H, Liu C, et al. Risk factors of transient cortical blindness after cerebral angiography: a multicenter study. Front Neurol. 2019;10:1005.
31. Mariajoseph FP, Lai LT, Praeger A, et al. The Australian Diagnostic Criteria for Contrast-Induced Encephalopathy. Neuroradiology. Published online 2025:1-7.
-
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/99590-
dc.description.abstract顯影劑誘發性腦病變(Contrast-Induced Encephalopathy, CIE)是急性缺血性中風接受血管內取栓術後罕見但嚴重的併發症。本研究旨在探討與 CIE 相關的臨床及 影像風險因子。
本研究為前瞻性資料蒐集回顧性分析研究,蒐集 2015 年九月至 2024 年八月間於台大醫院接受血管內取栓術治療患者其臨床資料、實驗室檢驗結果、影像特徵與 顯影劑使用量,並以無母數方法分析。
共 887 位患者納入分析,其中 22 位(2.48%)發生 CIE。CIE 患者年齡較高、體重較輕,具有較高比例的既往中風、心臟疾病及腎功能不全,並接受較高濃度的顯影劑。Firth 校正邏輯回歸分析顯示,較低的 eGFR(OR 0.96; 95% CI, 0.94– 0.98)、既往中風(OR 2.58; 95% CI, 1.02–6.51)、M2 段阻塞(OR 3.53;95% CI, 1.39–8.92)及較高的體重校正顯影劑劑量(OR 3.96; 95% CI, 1.57–10.02)皆為 CIE 的獨立風險因子。CIE 雖未與死亡率增加相關,但與較差的功能預後有關。
結論:腎功能不良、既往中風、大腦中動脈 M2 段阻塞及過量顯影劑使用與 CIE 風險升高相關。術前個體化顯影劑劑量調整與風險評估有助於降低 CIE 風險並改 善血管內取栓術後恢復情形。
zh_TW
dc.description.abstractBackground Contrast-Induced Encephalopathy (CIE) is a rare but serious complication after endovascular thrombectomy (EVT) for acute ischemic stroke. This study aimed to identify clinical and imaging risk factors for CIE.
Method We retrospectively reviewed 887 patients who received EVT between September 2015 and August 2024 at National Taiwan University Hospital. Clinical profiles, laboratory data, imaging features, and contrast usage were analyzed by non-parametric statistical methods. Firth’s penalized logistic regression was employed to identify independent risk factor of CIE, accounting for rare event bias.
Results There are 887 patients analyzed and CIE occurred in 22 patients (2.48%). These patients were older, had lower body weight, more prior stroke, heart disease, renal impairment, and higher contrast concentration. Firth’s logistic regression showed that lower eGFR (OR 0.96; 95% CI, 0.94–0.98), prior stroke (OR 2.58; 95% CI, 1.02–6.51), M2 occlusion (OR 3.53; 95% CI, 1.39–8.92), and higher contrast concentration (OR 3.96; 95% CI, 1.57–10.02) were independently associated with CIE. CIE was not associated with increased mortality but was linked to poorer functional outcomes. Conclusion Poor renal function, previous stroke, occlusion at M2, and excessive contrast dosing are associated with CIE. Individualized contrast dosing and pre- procedural risk stratification may reduce CIE risk and improve post-EVT recovery.
en
dc.description.provenanceSubmitted by admin ntu (admin@lib.ntu.edu.tw) on 2025-09-16T16:12:42Z
No. of bitstreams: 0
en
dc.description.provenanceMade available in DSpace on 2025-09-16T16:12:42Z (GMT). No. of bitstreams: 0en
dc.description.tableofcontents口試委員會審定書 ..................................................... ii
誌謝 ................................................................ iii
中文摘要 ............................................................. iv
Abstract ............................................................ v
Table of Contents.................................................... vi
List of Figures ..................................................... viii
List of Tables....................................................... ix
Chapter 1. Introduction ............................................... 1
1.1 Endovascular thrombectomy in acute ischemic stroke.......................... 1
1.2 Contrast-Induced encephalopathy.................................................. 2
1.3 Brain blood barrier in acute ischemic stroke..................................................... 3
1.4 Hypothesis and study objectives.......................................................................... 4
Chapter 2. Material and Methods................................................................................. 5
2.1 Study Population................................................................................................... 5
2.2 Thrombectomy Procedure ................................................................................... 8
2.3 Diagnosis of CIE ................................................................................................. 10
2.4 Statistical analysis and visualization................................................................. 11
Chapter 3. Results......................................................................................................... 13
Chapter 4. Discussion ................................................................................................... 15
4.1 In Addition to renal function and previous stroke, weight-adjusted contrast dose and target lesion site are also risk factors for CIE........................................ 15
4.2 M2 segment occlusions may increase CIE risk ................................................ 16
4.3 CIE may not increase mortality, but affects recovery .................................... 17
4.4 Study limitations ................................................................................................. 18
Chapter 5. Conclusion and future perspectives......................................................... 19
Reference ....................................................................................................................... 20 Appendix........................................................................................................................ 24
1. Figures ................................................................................................................... 24
2. Tables..................................................................................................................... 30
-
dc.language.isoen-
dc.subject急性缺血性腦中風zh_TW
dc.subject顯影劑誘發性腦病變zh_TW
dc.subject慢性腎病zh_TW
dc.subject血管內取栓術zh_TW
dc.subjectchronic kidney diseaseen
dc.subjectFunctional Outcomeen
dc.subjectContrast-Induced Encephalopathyen
dc.subjectStrokeen
dc.subjectM2 Occlusionen
dc.subjectContrast mediaen
dc.subjectEndovascular Thrombectomyen
dc.title臨床與影像特色與動脈取栓後顯影劑引起的腦病風險zh_TW
dc.titleClinical and image features and risk of Contrast-induced encephalopathy after endovascular thrombectomyen
dc.typeThesis-
dc.date.schoolyear113-2-
dc.description.degree碩士-
dc.contributor.coadvisor李崇維zh_TW
dc.contributor.coadvisorChung-Wei Leeen
dc.contributor.oralexamcommittee鄭建興;楊偉勛zh_TW
dc.contributor.oralexamcommitteeJiann-Shing Jeng;Wei-Shiung Yangen
dc.subject.keyword顯影劑誘發性腦病變,急性缺血性腦中風,血管內取栓術,慢性腎病,zh_TW
dc.subject.keywordContrast-Induced Encephalopathy,Endovascular Thrombectomy,Stroke,chronic kidney disease,Contrast media,M2 Occlusion,Functional Outcome,en
dc.relation.page43-
dc.identifier.doi10.6342/NTU202503122-
dc.rights.note同意授權(限校園內公開)-
dc.date.accepted2025-08-04-
dc.contributor.author-college醫學院-
dc.contributor.author-dept臨床醫學研究所-
dc.date.embargo-lift2030-07-31-
顯示於系所單位:臨床醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-113-2.pdf
  未授權公開取用
2.63 MBAdobe PDF檢視/開啟
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved